Malaria antibody persistence correlates with duration of exposure
- 8 November 2012
- journal article
- research article
- Published by Wiley in Vox Sanguinis
- Vol. 104 (4) , 292-298
Abstract
Background and Objectives In Australia, the risk of transfusion‐transmitted malaria is managed through the identification of ‘at‐risk’ donors, antibody screening enzyme‐linked immunoassay (EIA) and, if reactive, exclusion from fresh blood component manufacture. Donor management depends on the duration of exposure in malarious regions (>6 months: ‘Resident’, Materials and Methods Test results and demographic data from donors who were malaria EIA reactive were analysed. Time since possible exposure was estimated and antibody survival modelled.Results Among seroreverters, the time since last possible exposure was significantly shorter in ‘Visitors’ than in ‘Residents’. The antibody survival modelling predicted 20% of previously EIA reactive ‘Visitors’, but only 2% of ‘Residents’ would become non‐reactive within 3 years of their first reactive EIA.Conclusion Antibody persistence in donors correlates with exposure category, with semi‐immune ‘Residents’ maintaining detectable antibodies significantly longer than non‐immune ‘Visitors’.Keywords
This publication has 16 references indexed in Scilit:
- Assessing the safety and efficacy of a test-based, targeted donor screening strategy to minimize transfusion transmitted malariaVox Sanguinis, 2010
- Overview of revised measures to prevent malaria transmission by blood transfusion in FranceVox Sanguinis, 2008
- Malaria and blood transfusionVox Sanguinis, 2006
- Documented cases of post‐transfusion malaria occurring in England: a review in relation to current and proposed donor‐selection guidelinesVox Sanguinis, 2005
- The Current Status and Potential Role of Laboratory Testing to Prevent Transfusion-Transmitted MalariaTransfusion Medicine Reviews, 2005
- The efficacy of a malarial antibody enzyme immunoassay for establishing the reinstatement status of blood donors potentially exposed to malariaVox Sanguinis, 2005
- Evaluation of a malarial antibody assay for use in the screening of blood and tissue products for clinical useVox Sanguinis, 2004
- Transfusion-transmitted malariaIntensive Care Medicine, 2004
- An outbreak of Plasmodium vivax malaria in Far North Queensland, 2002Medical Journal of Australia, 2004
- Transfusion-Transmitted Malaria in the United States from 1963 through 1999New England Journal of Medicine, 2001